The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn’s Disease but Not Ulcerative Colitis PatientsYoung Su Park, Declan F. McCole, Michael J. Docherty et al.|Pharmaceutics|2023Cited by 10
A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosaDeclan F. McCole, Ronald R. Marchelletta, Harrison M. Penrose et al.|Pharmacology Research & Perspectives|2015Cited by 8
Tu1391 Different Dosing Regimens Modify Ion Transport Responses of Human Colonic Biopsies to Linaclotide vs. LubiprostoneDeclan F. McCole, Harrison M. Penrose, Michael J. Docherty et al.|Gastroenterology|2015Cited by 0
Tu1323 Lubiprostone Improves Electrical Resistance in Colonic Biopsies From Crohn's Disease but Not Ulcerative Colitis Patients Despite Reduced Ion Transport ResponsivenessYoung Su Park, Declan F. McCole, Ronald R. Marchelletta et al.|Gastroenterology|2012Cited by 0